Previous studies have also shown that in vitro modified CLL cells hyper-expressing adhesion molecules B7-1, ICAM-1 and LFA-3 [42], CD40 ligand [43] or both CD40 ligand and IL-2 [44] may enhance effective T cell responses against CLL cells. Here, CD58 is linked to B-cell chronic lymphocytic leukemia.